Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAPIS: Ticagrelor With Aspirin Dual Antiplatelet Therapy Combined With Intravenous Thrombolysis in Patients With Ischemic Stroke
NCT06316570Phase 3Completed
- Sponsor
- Beijing Tiantan Hospital
- Start
- Apr 2024
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ticagrelor, aspirin in ischemic stroke, sponsored by Beijing Tiantan Hospital. Started Apr 2024; status: completed.
02
Drugs
ticagreloraspirin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06316570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06316570.